Epic Update:Glenmark Pharmaceuticals

[Epicresearch123]

Glenmark Pharmaceuticals shot up as much as 5 percent to touch a four-year high of Rs 546.60 on Wednesday on Morgan Stanley report.

The foreign research firm Morgan Stanley has put an overweight rating on the stock due to strong earnings driven by growth in attractive markets like Brazil and Russia, lucrative therapies and focus on niche opportunities in the US.

At 14:44 hours IST, the stock rose 4.02 percent to Rs 540.60 on the Bombay Stock Exchange.